Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Research Abstract |
Knockdown of LTBP-1L or LTBP-1S in cancer cell lines including stomach cancer, ovarian cancer, uterine cancer, colorectal cancer, had no remarkable change in cell shape, cell growth and cell invasion activity. Forced expression of LTBP-1L or LTBP-1S also showed no remarkable effect on cancer cell lines. On the other hand, there was correlation between LTBP-1 expression and cancer - stroma relationship of stomach cancer by immunohistochemical analysis in clinical samples (p < 0.01). Thus, it was suggested that LTBP-1 can be a candidate of the diagnostic marker and the target of medical treatment. However, further studies were required to determine the LTBP-1L and LTBP-1S function.
|